Landscapes / Companies

Otsuka

Japan

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
5 approved
4 in Phase 3
Next date
SEP-380135, Phase 1 trial completes
Drugs
15
in active trials · 68 in all
Trials
35 active
254 since 2021

Drugs15

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
Approved 13 Mar 2027Phase 2 trial completes
Norepinephrine, dopamine and serotonin reuptake inhibitor
Approved 27 May 2027Phase 3 trial completes
OPC-34712FUMnot checked
—
Approved Sep 2027Phase 3 trial completes
Vasopressin V2 receptor antagonist
Approved 28 Dec 2028Phase 3 trial completes
—
Approved —
—
Phase 3 Dec 2026Phase 3 trial completes
—
Phase 3 1 Nov 2027Phase 3 trial completes
—
Phase 3 Mar 2028Phase 3 trial completes
—
Phase 3 29 Sep 2028Phase 3 trial completes
—
Phase 1/2 30 Jun 2027Phase 1/2 trial completes
VIS954not checked
—
Phase 2 13 Mar 2029Phase 2 trial completes
SEP-380135not checked
—
Phase 1 2 Dec 2026soonPhase 1 trial completes
—
Phase 1 25 Aug 2027Phase 1 trial completes
—
Phase 1 20 Nov 2028Phase 1 trial completes
—
Phase 1 —

About

No active trial
53 other drugs
SEC filings
None: it does not file with the US SEC
Registry names
7 names in ClinicalTrials.gov
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Otsuka

Following is part of Solo: you see every change to Otsuka the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in